According to a recent article in the magazine: Molecular and Cellular Proteomics, a series of experiments suggest that sperm can get the ATP (adenosine triphosphate) that gives them the energy to move, from the fatty acid metabolized by peroxisomal and mitochondrial pathways. To know that these metabolic enzymes are in human sperm would mean a significant progress in the knowledge of the metabolism of spermatozoa. The study has been carried out by Dr. Alexandra Amaral, Dr. Rafael Oliva, and Dr. Josep Lluís Ballesca, from the Research Group Human Genetics IDIBAPS, Hospital Clínic and the Department of Physiological Sciences, Faculty of Medicine University of Barcelona. Dr. Oliva also heads the Marie Curie Initial Training Network REPROTRAIN (Reproductive Biology Early Research Training), funded by the European Commission, which aims to train a new generation of researchers in Male Reproductive Biology and Andrology. Read the rest of this entry »
Archive for the ‘Hospital Clínic’ Category
Dr. Jordi Bruix leads a document that establishes radiological diagnostic criteria for hepatocellular carcinoma in the US
The American Society of Radiology publishes in its journal Radiology an updated article summarizing the new recommendations to diagnose and follow patients with hepatocellular carcinoma considered for liver transplantation in the United States. The document is the result of a task force created in 2008 in the heart of an expert conference organized by UNOS (the american organ distribution agency). Dr. Jordi Bruix, head of the Hepatic Oncology IDIBAPS – Hospital Clínic research team, participated as an international expert in the field of diagnosis and treatment of liver cancer. He is the last author of this document that defines the strategy in the US, which includes other internationally renowned experts from institutions such as Tufts University Medical School, Carolinas Medical Center, Mayo Clinic and University of Michigan Hospital.
A multi-million Euro initiative is bringing together researchers from across the world to develop new diagnostic tools and new treatments for people with rare diseases and to connect research data in this area on a global scale. Rare diseases – while individually uncommon – affect one person in every 17 and 80% have a genetic component. Today, the EU has announced 38 million Euro funding for research towards new treatments and for the development of a central global rare disease hub involving 70 institutions that will allow scientists to share data from their genomics research projects. Dr. Joan Lluis Vives-Corrons, a physician from IDIBAPS-Hospital Clínic and coordinator of ENERCA, is an associated partner of one of those projects.
The UPC and the Hospital Clínic de Barcelona create a device for rehabilitating the pelvic floor at home
A team of researchers at the Biomedical Engineering Research Centre (CREB) of the UniversitatPolitècnica de Catalunya – BarcelonaTech (UPC) and the Pelvic Floor Unit of the Hospital Clínicde Barcelona have developed a high-performance device for rehabilitating the pelvic floor at home. The device offersadvanced features, similar to those used in clinical practice.
Exercises to rehabilitate the pelvic floor are recommended as the initial treatment for urinary incontinence, a problem affecting more than 81 million people worldwide, most of them women. In Spain 15% of women in the general population and 25% of women aged 65 years and over suffer from this complaint. Performing voluntary contractions of the pelvic floor muscles requires training to ensure that the right muscles are activated and that the contraction is performed correctly.If the patient forces the muscles of the abdomen, the problem may be aggravated.
Acute uncomplicated lower-respiratory-tract infection, understood as cough of no more than 28 days’ duration, is the most common acute illness managed in primary care in developed countries. Even in low-antibiotic-prescribing countries, most patients with these symptoms will receive antibiotics. Although consensus opinion has been to restrict antibiotic use in such infections, the debate about the balance of benefit and harm continues. The Lancet Infectious Diseases has published an article led by the GRACE consortium addressing this problem. The work, involving over 2.000 patients in 12 countries, concludes that amoxicillin provides little benefit for acute lower respiratory-tract infection in primary care, when pneumonia is not suspected clinically. One of the authors of the article is Dr. Antoni Torres, full Professor at the University of Barcelona faculty of Medicine and leader of the IDIBAPS team Applied research in infectious respiratory diseases, critically ill patients and lung cancer. He coordinated, together with Dr. Núria Sánchez and the nurse Patricia Fernández, the tasks developed by the professionals at Casanova Primary Care Center (CAP Casanova, Barcelona).
Information via: www.idibapsrespiratoryresearch.org